弥漫大B细胞淋巴瘤进展概要1.pptVIP

New Approach for Elderly DLBCL in 2013 ASH Dose Of Vincristine didn’t Predict Outcome Of Treatment For Elderly DLBCL Patients The median doses of ADR, CPM, and VCR were 69.51±15.2%, 70.23±20.0% and 59.1±28.1% of original regimen, respectively. % of VCR to original CHOP regimen was significant different between age 70-79 and age more than 80 (p0.0001), but OS by % of actual dose VCR to original CHOP was not different (50% vs. ≧50%, p=0.62), suggesting that dose of VCR didn’t predict outcome of treatment. It might suggest that dose of VCR could be reduced with keeping treatment outcome to i